Societe Generale’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Societe Generale’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$8.25M	Buy	+92,206	New	+$8.47M	0.06%	254

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return

Societe Generale's FBT Position: Q2 2016 in Review

Societe Generale opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2016: 92,206 shares worth $8.25M. The stake represents 0.06% of the portfolio and ranks #254 among its holdings.

107 funds tracked by Wall St. Rank hold FBT as of Q2 2016.

Societe Generale held 92,206 shares of First Trust NYSE Arca Biotechnology Index Fund worth $8.25M as of Q2 2016.
First Trust NYSE Arca Biotechnology Index Fund was a new Societe Generale position in Q2 2016.
First Trust NYSE Arca Biotechnology Index Fund made up 0.06% of Societe Generale's portfolio in Q2 2016, its #254 holding.
107 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.